Is ARTIVION, INC. (AORT) Halal?

NYSE Healthcare United States $1.7B
✓ HALAL
Confidence: 95/100
ARTIVION, INC. (AORT) is Halal under all 5 major Shariah screening standards. With a debt ratio of just 14.5% against the AAOIFI threshold of 30%, ARTIVION, INC. comfortably passes the key financial ratio tests. The company operates in the Healthcare sector (Medical Devices), which is not a prohibited industry under Islamic finance principles.

Shariah Screening — 5 Standards

Based on financial data from December 2025

Standard Debt Ratio Cash Ratio Receivables Income Status
AAOIFI 14.5%
/ 30%
3.7%
/ 30%
5.8%
/ 30%
0.17%
/ 5%
✓ HALAL
DJIM 14.5%
/ 33%
3.7%
/ 33%
5.8%
/ 33%
0.17%
/ 5%
✓ HALAL
MSCI 29.1%
/ 33%
7.3%
/ 33%
11.7%
/ 33%
0.17%
/ 5%
✓ HALAL
S&P 14.5%
/ 33%
3.7%
/ 33%
5.8%
/ 33%
0.17%
/ 5%
✓ HALAL
FTSE 29.1%
/ 33%
7.3%
/ 33%
11.7%
/ 50%
0.17%
/ 5%
✓ HALAL

Financial Highlights

P/E Ratio
168.0
Forward: 30.5
EPS
$0.21
P/B Ratio
3.8
EV/EBITDA
35.0
EV: $1.9B
Revenue
$441M
Growth: 19.2%
Beta
1.6
High volatility
Current Ratio
3.5

Profitability

Gross Margin 64.4%
Operating Margin 8.1%
Net Margin 2.2%
Return on Equity (ROE) 2.7%
Return on Assets (ROA) 2.3%

Cash Flow & Balance Sheet

Operating Cash Flow$40M
Free Cash Flow$839,000
Total Debt$258M
Debt-to-Equity57.7
Current Ratio3.5
Total Assets$885M

Price & Trading

Last Close$36.39
50-Day MA$38.75
200-Day MA$39.93
Avg Volume385K
Beta1.6
52-Week Range
$21.97
$48.25

About ARTIVION, INC. (AORT)

CEO
Mr. James Patrick Mackin
Employees
1,800
Sector
Healthcare
Industry
Medical Devices
Country
United States
Exchange
NYSE
Market Cap
$1.7B
Currency
USD

Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers On-X prosthetic aortic and mitral heart valves; On-X ascending aortic prosthesis; CarbonAid CO2 diffusion catheters; Chord-X ePTFE sutures; pyrolytic carbon coating services; E-vita Open NEO, a hybrid stent graft; Arcevo, an LSA hybrid stent graft system; AMDS hybrid prosthesis; and NEXUS ONE, an endovascular stent graft system. It also provides NEXUS DUO, an aortic arch system; NEXUS TRE, a custom-made three branch graft; E-vita thoracic 3G, a stent graft system; E-xtra Design Engineering, a range of stent graft systems for the treatment of aortic vascular diseases, such as TAAA and Artivex; E-nside, a multibranch stent graft system; E-tegra, an AAA stent graft system; E-ventus BX and Tuva BX balloon-expandable peripheral stent grafts; and E-liac, a stent graft used to treat aneurysmal iliac arteries. In addition, the company offers synthetic vascular grafts that are used in open aortic and peripheral vascular surgical procedures; BioGlue, a surgical sealant; CryoValve SG pulmonary heart valve; CryoPatch SG pulmonary cardiac patch; SynerGraft, a decellularization technology; vascular preservation services; and PhotoFix, a bovine pericardial patch fixated. It markets its products and preservation services primarily to physicians through a direct sales team to hospitals and other healthcare facilities. The company was formerly known as CryoLife, Inc. and changed its name to Artivion, Inc. in January 2022. Artivion, Inc. was incorporated in 1984 and is headquartered in Kennesaw, Georgia.

Purification Calculator

As a halal stock with 0.17% impermissible income, you need to purify your dividends.

Enter your dividends to calculate purification amount

Related Halal Stocks in Healthcare

Frequently Asked Questions

Is ARTIVION, INC. (AORT) halal to invest in?

Based on our screening using AAOIFI Standard 21 (the strictest methodology), ARTIVION, INC. is Halal. The company passes all financial ratio thresholds for debt, cash, receivables, and impermissible income. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.

What is ARTIVION, INC.'s debt ratio?

ARTIVION, INC.'s debt ratio is 14.5% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 29.1%.

Does ARTIVION, INC. require dividend purification?

Yes, ARTIVION, INC. has an impermissible income ratio of 0.17%, which means 0.17% of any dividends received should be donated to charity as purification. This is because a small portion of the company's revenue comes from non-Shariah-compliant sources.

What are ARTIVION, INC.'s key financial metrics?

ARTIVION, INC. has a market capitalization of $1.7B, trailing P/E ratio of 168.0, and revenue of $441M. The company maintains a gross margin of 64.4% and a net margin of 2.2%. Return on equity stands at 2.7%.

How often is the screening data updated?

Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.

Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.